VTRS Q2 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.0B+15.7% YoY

Gross Profit

$1.2B41.4% margin

Operating Income

$474M16.0% margin

Net Income

$297M10.0% margin

EPS (Diluted)

$0.55

QoQ Revenue Growth

+8.9%

Cash Flow

Operating Cash Flow

$568M

Free Cash Flow

$517M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$35.5B

Total Liabilities

$22.7B

Stockholders' Equity

$12.8B

Cash & Equivalents

$613M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$2.6B	+15.7%
Gross Profit	$1.2B	$1.2B	+4.6%
Operating Income	$474M	$411M	+15.3%
Net Income	$297M	$168M	+76.4%